Cryogenic Vials Market is estimated to increase at a growth rate of 5.4% CAGR over the forecast period from 2024 to 2030.
The global Cryogenic Vials Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Internally threaded cryogenic vials, Externally threaded cryogenic vials ), By End-User (Research organization, Drug manufacturers, Healthcare institutions, Others).
An Introduction to Cryogenic Vials Market in 2024
The Cryogenic Vials Market involves specialized containers designed for the storage and preservation of biological samples, cell cultures, DNA/RNA samples, and other sensitive materials at ultra-low temperatures. Cryogenic vials are made from materials such as polypropylene or borosilicate glass, capable of withstanding cryogenic temperatures below -150°C without compromising sample integrity. These vials are essential in research laboratories, biorepositories, and healthcare facilities for long-term cryopreservation and sample management.
Cryogenic Vials Market Competitive Landscape
The global Cryogenic Vials Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Cryogenic Vials Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Cryogenic Vials Industry include- AHN Biotechnologie GmbH, Avantor Inc, Azer Scientific Inc, Biologix Group Ltd, Brooks Automation Inc, Cole Parmer Instrument Co. LLC, Corning Inc, DWK Life Sciences GmbH, EZ BioResearch LLC, LVL Technologies GmbH & Co. KG, Merck KGaA, Narang Medical Ltd, Pioneer Impex, SARSTEDT AG & Co. KG, Starlab International GMBH, Sumitomo Bakelite Co. Ltd, Thermo Fisher Scientific Inc, Wuxi NEST Biotechnology Co. Ltd, Ziath Ltd.
Cryogenic Vials Market Trend: Increased Adoption of RFID and Barcode Technologies for Sample Tracking and Inventory Management
A prominent trend in the cryogenic vials market is the increased adoption of RFID (Radio Frequency Identification) and barcode technologies for sample tracking and inventory management, driven by the need for efficient sample identification, traceability, and data management in biobanking and research laboratories. Cryogenic vials are essential containers used for the storage and preservation of biological specimens, cell cultures, and sensitive reagents at ultra-low temperatures (-80°C to -196°C). With the growing volume and complexity of samples in biorepositories and biobanks, there is a demand for automated tracking solutions that streamline sample management workflows, minimize errors, and improve operational efficiency. RFID and barcode technologies enable quick and accurate identification of cryogenic vials, allowing researchers to track sample movement, storage location, and storage duration in real time. By integrating RFID tags or barcode labels with laboratory information management systems (LIMS) and inventory databases, users can access detailed information about sample history, experimental protocols, and quality control measures, enhancing data integrity and regulatory compliance. Additionally, RFID-enabled cryogenic vials offer advantages such as non-contact scanning, long-range detection, and resistance to harsh environmental conditions, making them ideal for high-throughput screening and robotic handling applications. As laboratories seek to optimize sample management processes and ensure sample integrity, the adoption of RFID and barcode technologies in cryogenic vial storage systems is expected to grow, driving market expansion and innovation in sample tracking solutions.
Cryogenic Vials Market Driver: Growing Demand for Biopreservation Solutions in Cell Therapy and Regenerative Medicine Applications
A key driver propelling the cryogenic vials market is the growing demand for biopreservation solutions in cell therapy and regenerative medicine applications, fueled by advancements in stem cell research, tissue engineering, and personalized medicine. Cryogenic vials play a critical role in preserving the viability and functionality of biological samples, including stem cells, primary cells, and tissue grafts, for use in cell-based therapies and regenerative medicine treatments. With the increasing clinical translation of cell therapies for treating degenerative diseases, genetic disorders, and traumatic injuries, there is a need for reliable storage solutions that maintain the stability and potency of therapeutic cells during long-term cryopreservation. Cryogenic vials provide a secure and contamination-free environment for storing precious biological specimens at ultra-low temperatures, ensuring their integrity and suitability for downstream applications. Furthermore, the emergence of cryopreservation protocols for preserving complex tissue constructs, such as organoids, bioinks, and engineered tissues, further drives demand for cryogenic vials with specialized features, such as sterile packaging, leak-proof seals, and certified biocompatibility. As the field of regenerative medicine continues to advance, and cell therapy applications expand to diverse therapeutic areas, the demand for cryogenic vials is expected to rise, supporting market growth and innovation in biopreservation technologies.
Cryogenic Vials Market Opportunity: Development of Eco-Friendly and Biodegradable Cryogenic Vials to Reduce Environmental Impact
An emerging opportunity in the cryogenic vials market lies in the development of eco-friendly and biodegradable vials to address environmental concerns and promote sustainable laboratory practices. Traditional cryogenic vials are typically made from polypropylene or polycarbonate plastics, which are non-biodegradable and contribute to plastic waste accumulation in landfills and oceans. As sustainability becomes a key focus area for research institutions, biobanks, and pharmaceutical companies, there is a growing demand for alternative materials and manufacturing processes that reduce the environmental footprint of cryogenic vials. Eco-friendly cryogenic vials may incorporate bioplastics, recycled materials, or compostable polymers that degrade naturally over time, minimizing environmental impact and promoting circular economy principles. Additionally, manufacturers can explore innovative packaging designs, such as reusable vial racks and reduced packaging waste, to further enhance the sustainability profile of cryogenic vials. By investing in the development of eco-friendly alternatives, manufacturers can align with sustainability initiatives, meet regulatory requirements for eco-labeling, and differentiate their product offerings in the market, catering to the increasing demand for environmentally responsible laboratory consumables.
Market Share Analysis: Internally Threaded Cryogenic Vials for Drug Manufacturers is the fastest growing segment in the Cryogenic Vials industry
Among cryogenic vial types, internally threaded cryogenic vials for drug manufacturers are experiencing the fastest growth. This surge is propelled by the increasing demand for high-quality vials capable of securely storing sensitive biological materials and pharmaceutical products at ultra-low temperatures. Internally threaded cryogenic vials offer advantages such as superior sealing capabilities, reduced risk of sample contamination, and enhanced compatibility with automated storage systems, making them particularly well-suited for the stringent requirements of drug manufacturing processes. With the pharmaceutical industry witnessing rapid advancements in biopharmaceuticals, personalized medicine, and vaccine development, there is a growing need for reliable cryogenic vials to preserve the efficacy and stability of these valuable products throughout storage and transportation. Moreover, as drug manufacturers prioritize quality assurance and regulatory compliance, the adoption of internally threaded cryogenic vials ensures the integrity and traceability of pharmaceutical samples, driving significant growth in this segment. Thus, the market for internally threaded cryogenic vials tailored for drug manufacturers is poised for continued expansion, driven by the evolving needs of the pharmaceutical industry and the imperative to maintain product quality and safety standards.
Cryogenic Vials Market Segmentation
By Type
Internally threaded cryogenic vials
Externally threaded cryogenic vials
By End-User
Research organization
Drug manufacturers
Healthcare institutions
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Cryogenic Vials Companies
AHN Biotechnologie GmbH
Avantor Inc
Azer Scientific Inc
Biologix Group Ltd
Brooks Automation Inc
Cole Parmer Instrument Co. LLC
Corning Inc
DWK Life Sciences GmbH
EZ BioResearch LLC
LVL Technologies GmbH & Co. KG
Merck KGaA
Narang Medical Ltd
Pioneer Impex
SARSTEDT AG & Co. KG
Starlab International GMBH
Sumitomo Bakelite Co. Ltd
Thermo Fisher Scientific Inc
Wuxi NEST Biotechnology Co. Ltd
Ziath Ltd
* List not Exhaustive
Reasons to Buy the Cryogenic Vials Market Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Cryogenic Vials Market Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Cryogenic Vials Market Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Cryogenic Vials Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Cryogenic Vials Market Size Outlook, $ Million, 2021 to 2030
3.2 Cryogenic Vials Market Outlook by Type, $ Million, 2021 to 2030
3.3 Cryogenic Vials Market Outlook by Product, $ Million, 2021 to 2030
3.4 Cryogenic Vials Market Outlook by Application, $ Million, 2021 to 2030
3.5 Cryogenic Vials Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Cryogenic Vials Industry
4.2 Key Market Trends in Cryogenic Vials Industry
4.3 Potential Opportunities in Cryogenic Vials Industry
4.4 Key Challenges in Cryogenic Vials Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Cryogenic Vials Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Cryogenic Vials Market Outlook by Segments
7.1 Cryogenic Vials Market Outlook by Segments, $ Million, 2021- 2030
By Type
Internally threaded cryogenic vials
Externally threaded cryogenic vials
By End-User
Research organization
Drug manufacturers
Healthcare institutions
Others
8 North America Cryogenic Vials Market Analysis and Outlook To 2030
8.1 Introduction to North America Cryogenic Vials Markets in 2024
8.2 North America Cryogenic Vials Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Cryogenic Vials Market size Outlook by Segments, 2021-2030
By Type
Internally threaded cryogenic vials
Externally threaded cryogenic vials
By End-User
Research organization
Drug manufacturers
Healthcare institutions
Others
9 Europe Cryogenic Vials Market Analysis and Outlook To 2030
9.1 Introduction to Europe Cryogenic Vials Markets in 2024
9.2 Europe Cryogenic Vials Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Cryogenic Vials Market Size Outlook by Segments, 2021-2030
By Type
Internally threaded cryogenic vials
Externally threaded cryogenic vials
By End-User
Research organization
Drug manufacturers
Healthcare institutions
Others
10 Asia Pacific Cryogenic Vials Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Cryogenic Vials Markets in 2024
10.2 Asia Pacific Cryogenic Vials Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Cryogenic Vials Market size Outlook by Segments, 2021-2030
By Type
Internally threaded cryogenic vials
Externally threaded cryogenic vials
By End-User
Research organization
Drug manufacturers
Healthcare institutions
Others
11 South America Cryogenic Vials Market Analysis and Outlook To 2030
11.1 Introduction to South America Cryogenic Vials Markets in 2024
11.2 South America Cryogenic Vials Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Cryogenic Vials Market size Outlook by Segments, 2021-2030
By Type
Internally threaded cryogenic vials
Externally threaded cryogenic vials
By End-User
Research organization
Drug manufacturers
Healthcare institutions
Others
12 Middle East and Africa Cryogenic Vials Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Cryogenic Vials Markets in 2024
12.2 Middle East and Africa Cryogenic Vials Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Cryogenic Vials Market size Outlook by Segments, 2021-2030
By Type
Internally threaded cryogenic vials
Externally threaded cryogenic vials
By End-User
Research organization
Drug manufacturers
Healthcare institutions
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AHN Biotechnologie GmbH
Avantor Inc
Azer Scientific Inc
Biologix Group Ltd
Brooks Automation Inc
Cole Parmer Instrument Co. LLC
Corning Inc
DWK Life Sciences GmbH
EZ BioResearch LLC
LVL Technologies GmbH & Co. KG
Merck KGaA
Narang Medical Ltd
Pioneer Impex
SARSTEDT AG & Co. KG
Starlab International GMBH
Sumitomo Bakelite Co. Ltd
Thermo Fisher Scientific Inc
Wuxi NEST Biotechnology Co. Ltd
Ziath Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
